Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 30 checked references that resolve
resolves10.1002/ijc.22239Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases
resolves10.2307/2529873Cancer Survival Corrected for Heterogeneity in Patient Withdrawal
resolves10.1002/ijc.24320International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
resolves10.1016/j.ctrv.2010.11.003A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST
resolves10.1002/cncr.20862Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era
resolves10.1002/ijc.21167Gastrointestinal stromal tumors in Iceland, 1990–2003: The Icelandic GIST study, a population‐based incidence and pathologic risk stratification study
resolves10.1016/j.ejca.2006.07.015Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain
resolves10.1186/1471-2407-7-230Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study
resolves10.1002/pbc.23252Soft tissue sarcoma across the age spectrum: A population‐based study from the surveillance epidemiology and end results database
resolves10.2106/JBJS.H.00416Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER Database
resolves10.1016/j.ejca.2006.05.015Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project
resolves10.1093/annonc/mdh058Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas
resolves10.1038/sj.bjc.6602885Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980–1994
resolves10.1093/annonc/mdq644Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.